Your SlideShare is downloading. ×
  • Like


Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.


Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Geriatric Oncology Bibliography since 2001



  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On SlideShare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Geriatric Oncology Bibliography since 2001 Stuart M. Lichtman, MD 1. Balducci L: The geriatric cancer patient: equal benefit from equal treatment. Cancer Control 8:1-25; quiz 27-8., 2001 2. Balducci L, Lyman GH: Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol 19:1583-5., 2001 3. Chiara S, Lionetto R, Vincenti M, et al: Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy. Crit Rev Oncol Hematol 37:27-34., 2001 4. Franceschi S, La Vecchia C: Cancer epidemiology in the elderly. Crit Rev Oncol Hematol 39:219-26., 2001 5. Gridelli C: The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. Oncologist 6 Suppl 1:4-7, 2001 6. Hainsworth JD, Burris HA, 3rd, Yardley DA, et al: Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial. J Clin Oncol 19:3500-5, 2001 7. Hayman JA, Langa KM, Kabeto MU, et al: Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 19:3219-25., 2001 8. Kohne CH, Grothey A, Bokemeyer C, et al: Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 12:435-42., 2001 9. Niitsu N, Iijima K: Full-dose CHOP chemotherapy combined with granulocyte colony- stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study. Ann Hematol 80:602-6., 2001 10. Repetto L, Ausili-Cefaro G, Gallo C, et al: Quality of life in elderly cancer patients. Ann Oncol 12:S49-52., 2001 11. Sargent DJ, Goldberg RM, Jacobson SD, et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-7., 2001 12. Sundararajan V, Grann VR, Jacobson JS, et al: Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population- based study. Cancer J 7:213-8., 2001
  • 2. 13. Walter LC, Covinsky KE: Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285:2750-6, 2001 14. Burkhardt H, Bojarsky G, Gretz N, et al: Creatinine clearance, Cockcroft- Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly? Gerontology 48:140-6., 2002 15. Cohen HJ, Feussner JR, Weinberger M, et al: A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 346:905-12, 2002 16. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-42., 2002 17. Desai MM, Bogardus ST, Jr., Williams CS, et al: Development and validation of a risk-adjustment index for older patients: the high-risk diagnoses for the elderly scale. J Am Geriatr Soc 50:474-81, 2002 18. Extermann M, Chen H, Cantor AB, et al: Predictors of tolerance to chemotherapy in older cancer patients. a prospective pilot study. Eur J Cancer 38:1466-73, 2002 19. Fata F, Mirza A, Craig G, et al: Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer 94:1931-8, 2002 20. Gronlund B, Hogdall C, Hansen HH, et al: Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma. Cancer 94:1961-7., 2002 21. Ingram SS, Seo PH, Martell RE, et al: Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 20:770-5., 2002 22. Iwashyna TJ, Lamont EB: Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20:3992-8., 2002 23. Langer C, Hsu C, Curran W, et al: Do elderly patients with locally advanced non-small cell lung cancer (NSCLC) benefit from combined modality therapy? A secondary analysis of RTOG 94-10. Int J Radiat Oncol Biol Phys 51:20-21, 2002 24. Langer CJ, Manola J, Bernardo P, et al: Cisplatin-based therapy for elderly patients with advanced non-small- cell lung cancer: implications of eastern cooperative oncology group 5592, a randomized trial. J Natl Cancer Inst 94:173-81., 2002
  • 3. 25. Neugut AI, Fleischauer AT, Sundararajan V, et al: Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population- based study. J Clin Oncol 20:2643-50., 2002 26. Onder G, Pedone C, Landi F, et al: Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962-8., 2002 27. Repetto L, Balducci L: A case for geriatric oncology. Lancet Oncol 3:289-97, 2002 28. Repetto L, Fratino L, Audisio RA, et al: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20:494-502, 2002 29. Skirvin JA, Lichtman SM: Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Drugs Aging 19:25-42, 2002 30. Sundararajan V, Hershman D, Grann VR, et al: Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol 20:173-8., 2002 31. Sundararajan V, Mitra N, Jacobson JS, et al: Survival Associated with 5- Fluorouracil--Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer. Ann Intern Med 136:349-57., 2002 32. Apolone G, Cavuto S, Torri V, et al: Effectiveness of adjuvant fluorouracil in elderly colon cancer patients: the internal and external validity of nonrandomized research design. J Clin Oncol 21:1892; author reply 1893, 2003 33. Bai LY, Yang MH, Chiou TJ, et al: Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital. Cancer 98:1188-95, 2003 34. Balducci L, Carreca I: Supportive care of the older cancer patient. Crit Rev Oncol Hematol 48:S65-70, 2003 35. Beiderbeck-Noll AB, Sturkenboom MC, van der Linden PD, et al: Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer 39:98-105, 2003 36. Bernardi D, Milan I, Balzarotti M, et al: Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient-tailored treatment plan. J Clin Oncol 21:754; author reply 755, 2003
  • 4. 37. Biganzoli L, Aapro M: Adjuvant chemotherapy in the elderly. Ann Oncol 14 Suppl 3:iii1-3, 2003 38. Blamey RW: Management of primary breast cancer in the elderly patient. Eur J Cancer 39:286, 2003 39. Bouchardy C, Rapiti E, Fioretta G, et al: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21:3580-7, 2003 40. Bunn PA, Jr., Lilenbaum R: Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer. JNCI Cancer Spectrum 95:341-343, 2003 41. Chen H, Cantor A, Meyer J, et al: Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 97:1107-14, 2003 42. Doorduijn JK, van der Holt B, van Imhoff GW, et al: CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin's Lymphoma. J Clin Oncol 21:3041-3050, 2003 43. Earle CC, Burstein HJ, Winer EP, et al: Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 21:1447-51, 2003 44. Extermann M: Assessing elderly cancer patients. The SIOG Task Force on Oncogeriatric Assessment presents its findings to the experts. Cancer Futures 2:155-157, 2003 45. Extermann M, Albrand G, Chen H, et al: Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 21:3214-9, 2003 46. Extermann M, Yoder J, Overcash J, et al: Influence of p450-metabolized concomitant medications on toxicity from chemotherapy in older cancer patients. Proc Am Soc Clin Oncol 22:2937a, 2003 47. Fentiman IS, Christiaens MR, Paridaens R, et al: Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 39:309-16, 2003 48. Gridelli C, Perrone F, Gallo C, et al: Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial. J Natl Cancer Inst 95:362-72., 2003 49. Hurria A, Hudis C: Follow-up care of breast cancer survivors. Crit Rev Oncol Hematol 48:89-99, 2003
  • 5. 50. Hurria A, Kris MG: Management of lung cancer in older adults. CA Cancer J Clin 53:325-41, 2003 51. Hurria A, Leung D, Trainor K, et al: Factors influencing treatment patterns of breast cancer patients age 75 and older. Crit Rev Oncol Hematol 46:121-6, 2003 52. Hurria A, Leung D, Trainor K, et al: Screening chest imaging studies are not effective in the follow-up of breast cancer patients. J Oncol Manag 12:13-5, 2003 53. John V, Mashru S, Lichtman S: Pharmacological factors influencing anticancer drug selection in the elderly. Drugs Aging 20:737-59, 2003 54. Lichtman SM: Guidelines for the treatment of elderly cancer patients. Cancer Control 10:445-53, 2003 55. Lyman GH, Kuderer N, Agboola O, et al: Evidence-based use of colony- stimulating factors in elderly cancer patients. Cancer Control 10:487-99, 2003 56. Martelli G, Miceli R, De Palo G, et al: Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla? Cancer 97:1156-63, 2003 57. Osby E, Hagberg H, Kvaloy S, et al: CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 101:3840-8, 2003 58. Repetto L, Biganzoli L, Koehne CH, et al: EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 39:2264-72, 2003 59. Repetto L, Carreca I, Maraninchi D, et al: Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting. Crit Rev Oncol Hematol 45:123-8, 2003 60. Schild SE, Stella PJ, Geyer SM, et al: The Outcome of Combined-Modality Therapy for Stage III Non-Small-Cell Lung Cancer in the Elderly. J Clin Oncol 21:3201-3206, 2003 61. Sequist LV, Lynch TJ: Aggressive Treatment for the Fit Elderly With Non- Small-Cell Lung Cancer? Yes! J Clin Oncol, 2003 62. Swedko PJ, Clark HD, Paramsothy K, et al: Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 163:356-60., 2003
  • 6. 63. Turnheim K: When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38:843-53, 2003 64. Wildiers H, Highley MS, de Bruijn EA, et al: Pharmacology of anticancer drugs in the elderly population. Clin Pharmacokinet 42:1213-42, 2003 65. Argiris A, Li Y, Murphy BA, et al: Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 22:262-8, 2004 66. Audisio RA, Bozzetti F, Gennari R, et al: The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer 40:926-38, 2004 67. Balducci L, Repetto L: Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma. Cancer 100:6-11, 2004 68. Cova D, Balducci L: Cancer chemotherapy in the older patient., in Balducci L, Lyman GH, Ershler WB, et al (eds): Comprehensive geriatric oncology. Oxon, England, Taylor & Francis, 2004 69. Dang CT, D'Andrea GM, Moynahan ME, et al: Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer. Clin Cancer Res 10:5754-61, 2004 70. Extermann M: Pharmacokinetics of weekly docetaxel in elderly patients: how well can it be predicted? , Personal Communication, 2004 71. Extermann M, Bonetti M, Sledge GW, et al: MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 40:1193-8, 2004 72. Folprecht G, Cunningham D, Ross P, et al: Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol 15:1330-8, 2004 73. Hershman D, Fleischauer AT, Jacobson JS, et al: Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study. Gynecol Oncol 92:293-9, 2004 74. Hershman D, Jacobson JS, McBride R, et al: Effectiveness of platinum- based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol 94:540-9, 2004
  • 7. 75. Hess D, Thurlimann B, Pagani O, et al: Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99). Ann Oncol 15:1760-5, 2004 76. Lichtman SM: Chemotherapy in the elderly. Semin Oncol 31:160-74, 2004 77. Marx GM, Blake GM, Galani E, et al: Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 15:291-5, 2004 78. Matasar MJ, Sundararajan V, Grann VR, et al: Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy. Drugs Aging 21:113-33, 2004 79. Minami H, Ohe Y, Niho S, et al: Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients? J Clin Oncol 22:2901-8, 2004 80. Petignat P, Fioretta G, Verkooijen HM, et al: Poorer survival of elderly patients with ovarian cancer: a population-based study. Surg Oncol 13:181-6, 2004 81. Pfreundschuh M, Trumper L, Kloess M, et al: Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 104:634-41, 2004 82. Pignata S, Vermorken JB: Ovarian cancer in the elderly. Crit Rev Oncol Hematol 49:77-86, 2004 83. Rao A, Cohen HJ: Symptom Management in the Elderly Cancer Patient: Fatigue, Pain, and Depression. J Natl Cancer Inst Monographs 2004:150-157, 2004 84. Shah RR: Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II). Br J Clin Pharmacol 58:452-69, 2004 85. Talarico L, Chen G, Pazdur R: Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 22:4626-31, 2004 86. Tralongo P, Repetto L, Di Mari A, et al: Safety of long-term administration of bisphosphonates in elderly cancer patients. Oncology 67:112-6, 2004 87. Twelves C, Butts C, Cassidy J, et al: XELOX (capecitabine plus oxaliplatin), a safe and active first-line regimen for elderly patients with metastatic colorectal cancer (MCRC): Post-hoc analysis of a large phase II study. J Clin Oncol (Meeting Abstracts) 22:258-c-, 2004
  • 8. 88. Wright JD, Herzog TJ, Powell MA: Morbidity of cytoreductive surgery in the elderly. Am J Obstet Gynecol 190:1398-400, 2004 89. Aapro MS: The Frail Are Not Always Elderly. J Clin Oncol 23:2121-2122, 2005 90. Alliot C: CHOP Versus CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin's Lymphoma. J Clin Oncol 23:4797-4798, 2005 91. Alliot C: Undertreatment of Breast Cancer in Elderly Women: Contribution of a Cancer Registry. J Clin Oncol 23:4800-4801, 2005 92. Ardizzoni A, Favaretto A, Boni L, et al: Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study. J Clin Oncol 23:569-75, 2005 93. Balducci L: NCCN Clincal Practice Guidelines in Oncology. Senior Adult Oncology., 2005 94. Bamias A, Efstathiou E, Moulopoulos LA, et al: The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy. Ann Oncol 16:307-13, 2005 95. Cho D, Kocher O, Lee JC, et al: Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer. J Clin Oncol 23:235-7, 2005 96. Clark PE, Stein JP, Groshen SG, et al: Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Cancer 103:546-52, 2005 97. Comella P, Natale D, Farris A, et al: Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. Cancer 104:282-9, 2005 98. Engert A, Ballova V, Haverkamp H, et al: Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study Group. J Clin Oncol 23:5052-5060, 2005 99. Extermann M: Treating patients who have cognitive disorders and cancer. ASCO Educational Book:403-405, 2005
  • 9. 100. Extermann M: Older patients, cognitive impairment, and cancer: an increasingly frequent triad. J Natl Compr Canc Netw 3:593-6, 2005 101. Extermann M, Aapro M, Bernabei R, et al: Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55:241-252, 2005 102. Feugier P, Van Hoof A, Sebban C, et al: Long-Term Results of the R- CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23:4117-4126, 2005 103. Gridelli C, Aapro M, Ardizzoni A, et al: Treatment of Advanced Non-Small- Cell Lung Cancer in the Elderly: Results of an International Expert Panel. J Clin Oncol 23:3125-3137, 2005 104. Hurria A, Brogan K, Panageas KS, et al: Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Drugs Aging 22:709-15, 2005 105. Hurria A, Brogan K, Panageas KS, et al: Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 92:151-6, 2005 106. Hurria A, Gupta S, Zauderer M, et al: Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104:1998-2005, 2005 107. Hurria A, Hurria A, Brogan K, et al: Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer. Drugs Aging 22:785-91, 2005 108. Jatoi A, Hillman S, Stella P, et al: Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 23:9113-9, 2005 109. Libow LS: Geriatrics in the United States -- Baby Boomers' Boon? N Engl J Med 352:750-752, 2005 110. Maione P, Perrone F, Gallo C, et al: Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non--Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study. J Clin Oncol 23:6865-6872, 2005
  • 10. 111. Sastre J, Marcuello E, Masutti B, et al: Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. J Clin Oncol 23:3545-51, 2005 112. Schild SE, Stella PJ, Brooks BJ, et al: Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer 103:2349-54, 2005 113. Steyerberg EW, Earle CC, Neville BA, et al: Racial Differences in Surgical Evaluation, Treatment, and Outcome of Locoregional Esophageal Cancer: A Population-Based Analysis of Elderly Patients. J Clin Oncol 23:510-517, 2005 114. ten Tije AJ, Verweij J, Carducci MA, et al: Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly. J Clin Oncol 23:1070-1077, 2005 115. Townsley C, Pond GR, Peloza B, et al: Analysis of Treatment Practices for Elderly Cancer Patients in Ontario, Canada. J Clin Oncol 23:3802-3810, 2005 116. Uyar D, Frasure HE, Markman M, et al: Treatment patterns by decade of life in elderly women (>/=70 years of age) with ovarian cancer. Gynecol Oncol 98:403-8, 2005 117. Wright JD, Gibb RK, Geevarghese S, et al: Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer 103:85-91, 2005 118. Biganzoli L, Robert C, Alessandro M, et al: A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyxtrade mark) in the treatment of elderly patients with metastatic breast cancer. Crit Rev Oncol Hematol 61:84-89, 2006 119. Bottini A, Generali D, Brizzi MP, et al: Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients. J Clin Oncol 24:3623-8, 2006 120. Cohen HJ, Muss HB: The Cancer and Leukemia Group B Cancer in the Elderly Committee: Addressing a Major Cancer Need. Clin Cancer Res 12:3606s-3611s, 2006 121. Elkin EB, Hurria A, Mitra N, et al: Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol 24:2757-64, 2006
  • 11. 122. Ershler WB: Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data. Crit Rev Oncol Hematol 58:68-78, 2006 123. Feliu J, Salud A, Escudero P, et al: XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. Br J Cancer 94:969-75, 2006 124. Flood KL, Carroll MB, Le CV, et al: Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol 24:2298-303, 2006 125. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al: Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 24:4085-91, 2006 126. Grann VR, Hershman D, Jacobson JS, et al: Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma. Cancer 107:1530-1541, 2006 127. Hurria A: We need a geriatric assessment for oncologists. Nat Clin Pract Oncol 3:642-3, 2006 128. Hurria A, Fleming MT, Baker SD, et al: Pharmacokinetics and toxicity of weekly docetaxel in older patients. Clin Cancer Res 12:6100-5, 2006 129. Hurria A, Goldfarb S, Rosen C, et al: Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat 98:343-8, 2006 130. Hurria A, Hurria A, Zuckerman E, et al: A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc 54:1119-24, 2006 131. Hurria A, Lachs MS, Cohen HJ, et al: Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol 59:211-7, 2006 132. Hurria A, Rosen C, Hudis C, et al: Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54:925-31, 2006 133. Koroukian SM, Murray P, Madigan E: Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol 24:2304-10, 2006 134. Lichtman SM: Therapy insight: Therapeutic challenges in the treatment of elderly cancer patients. Nat Clin Pract Oncol 3:86-93, 2006
  • 12. 135. Mancuso A, Migliorino M, De Santis S, et al: Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 17:146-50, 2006 136. Naeim A, Hurria A, Leake B, et al: Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity. Crit Rev Oncol Hematol 59:234-42, 2006 137. Neugut AI, Matasar M, Wang X, et al: Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 24:2368-75, 2006 138. Punglia RS, Weeks JC, Neville BA, et al: Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. J Clin Oncol 24:3474-82, 2006 139. Raghavan D, Suh T: Cancer in the elderly population: the protection racket. J Clin Oncol 24:1795-6, 2006 140. Scardino PT: Surgery in elderly cancer patients. Nat Clin Pract Urol 3:397, 2006 141. Smith BD, Haffty BG, Hurria A, et al: Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 24:4901-7, 2006 142. Smith TJ, Khatcheressian J, Lyman GH, et al: 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline J Clin Oncol 24:3187-3205, 2006 143. Weiss GJ, Langer C, Rosell R, et al: Elderly patients benefit from second- line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non- small-cell lung cancer. J Clin Oncol 24:4405-11, 2006 144. Audisio RA, Zbar AP, Jaklitsch MT: Surgical management of oncogeriatric patients. J Clin Oncol 25:1924-9, 2007 145. Biganzoli L, Coleman R, Minisini A, et al: A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer. Crit Rev Oncol Hematol 61:84-9, 2007 146. Body JJ, Coleman R, Clezardin P, et al: International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients. Eur J Cancer 43:852-8, 2007
  • 13. 147. Bonnet C, Fillet G, Mounier N, et al: CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 25:787-92, 2007 148. Crivellari D, Aapro M, Leonard R, et al: Breast cancer in the elderly. J Clin Oncol 25:1882-90, 2007 149. Eisenhauer EL, Tew WP, Levine DA, et al: Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecol Oncol, 2007 150. Extermann M, Hurria A: Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25:1824-31, 2007 151. Gridelli C, Langer C, Maione P, et al: Lung cancer in the elderly. J Clin Oncol 25:1898-907, 2007 152. Gridelli C, Maione P, Rossi A: Single-agent chemotherapy for the treatment of elderly patients with advanced non-small-cell lung cancer: what is the best drug? J Clin Oncol 25:1444-5; author reply 1446, 2007 153. Hilpert F, du Bois A, Greimel E, et al: Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany. Ann Oncol 18:282-7, 2007 154. Horiot JC: Radiation therapy and the geriatric oncology patient. J Clin Oncol 25:1930-5, 2007 155. Hurria A: Clinical trials in older adults with cancer: past and future. Oncology (Williston Park) 21:351-8; discussion 363-4, 367, 2007 156. Hurria A, Lachs M: Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Res Treat, 2007 157. Hurria A, Lichtman SM: Pharmacokinetics of chemotherapy in the older patient. Cancer Control 14:32-43, 2007 158. Hurria A, Naeim A, Elkin E, et al: Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Crit Rev Oncol Hematol 61:255-60, 2007 159. Kumar A, Soares HP, Balducci L, et al: Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J Clin Oncol 25:1272-6, 2007
  • 14. 160. Lichtman SM: Pharmacokinetics and pharmacodynamics in the elderly. Clin Adv Hematol Oncol 5:181-2, 2007 161. Lichtman SM, Balducci L, Aapro M: Geriatric oncology: a field coming of age. J Clin Oncol 25:1821-3, 2007 162. Lichtman SM, Wildiers H, Chatelut E, et al: International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature. J Clin Oncol 25:1832-43, 2007 163. Lichtman SM, Wildiers H, Launay-Vacher V, et al: International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 43:14-34, 2007 164. Malani AK, Abou-Jawde RM, Singh J, et al: Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients. J Clin Oncol 25:1143-4; author reply 1144, 2007 165. Muss HB, Biganzoli L, Sargent DJ, et al: Adjuvant therapy in the elderly: making the right decision. J Clin Oncol 25:1870-5, 2007 166. Pepe C, Hasan B, Winton TL, et al: Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 25:1553-61, 2007 167. Rodin MB, Mohile SG: A practical approach to geriatric assessment in oncology. J Clin Oncol 25:1936-44, 2007 168. Surbone A, Kagawa-Singer M, Terret C, et al: The illness trajectory of elderly cancer patients across cultures: SIOG position paper. Ann Oncol 16:633-8, 2007 169. Tam-McDevitt JT, Balducci L, Hauser RS, et al: Has demand for clinical trial participants outpaced supply? J Natl Cancer Inst 99:86-7, 2007 170. Terret C, Zulian GB, Naiem A, et al: Multidisciplinary approach to the geriatric oncology patient. J Clin Oncol 25:1876-81, 2007 171. Wisnivesky JP, Halm EA: Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol 25:1705-12, 2007